Amerx

Lucid Capital Markets, LLC (dba AmerX)

AmerX is the trade name of Lucid Capital Markets, LLC, a New York self-clearing broker-dealer and NYSE floor broker. Its equity research, launched in May 2026, focuses on physical-AI, lidar and autonomy stocks, with technology-services names added later.

Company history

The firm was formed in New York in June 2015, operated as Americas Executions, LLC under chief executive Fady Tanios, and has held an NYSE trading license since August 3, 2015, succeeding a predecessor member organization registered in 2006. It built floor brokerage, direct market access, algorithmic trading, self-clearing, prime brokerage and securities lending businesses. The broker-dealer distributes research through two divisions: Lucid, focused on fundamental research, and AmerX.

  1. 2006Predecessor entity registers as NYSE member organization
  2. 2015Americas Executions formed; obtains NYSE trading license
  3. 2026AmerX launches equity research focused on physical AI

Research

AmerX research launched on May 5, 2026 with one senior analyst covering technology; its inaugural report initiated coverage of eight physical-AI companies in lidar, radar and autonomous software. It uses a five-tier system: Buy (total return of 35% or more over 12 months), Overweight (at least 15%), Hold (within ±14%), Underweight (−15% to −35%) and Sell (−35% or worse). It does not set price targets on Hold-rated stocks.

Coverage12M

Stocks
3
Ratings
4
Price targets
0
Upgrades
0
Downgrades
0
Initiations
0
Reiterations
4
  • Positive33%1
  • Neutral67%2
  • Negative0%0

Sectors

  • Information Technology67%
  • Consumer Discretionary33%

Ratings

  • Hold75%
  • Buy25%

Listing

  • United States67%
  • China33%

Activity24M

RatingsPrice targets3
Oct 2024 · Ratings 0 · Price targets 0Nov 2024 · Ratings 0 · Price targets 0Dec 2024 · Ratings 0 · Price targets 0Jan 2025 · Ratings 0 · Price targets 0Feb 2025 · Ratings 0 · Price targets 0Mar 2025 · Ratings 0 · Price targets 0Apr 2025 · Ratings 0 · Price targets 0May 2025 · Ratings 0 · Price targets 0Jun 2025 · Ratings 0 · Price targets 0Jul 2025 · Ratings 0 · Price targets 0Aug 2025 · Ratings 0 · Price targets 0Sep 2025 · Ratings 0 · Price targets 0Oct 2025 · Ratings 0 · Price targets 0Nov 2025 · Ratings 0 · Price targets 0Dec 2025 · Ratings 0 · Price targets 0Jan 2026 · Ratings 0 · Price targets 0Feb 2026 · Ratings 0 · Price targets 0Mar 2026 · Ratings 0 · Price targets 0Apr 2026 · Ratings 0 · Price targets 0May 2026 · Ratings 3 · Price targets 0Jun 2026 · Ratings 0 · Price targets 0Jul 2026 · Ratings 0 · Price targets 0Aug 2026 · Ratings 1 · Price targets 0Sep 2026 · Ratings 0 · Price targets 0
Oct '24Oct '25Sep '26

Most covered24M

StockRatingTargetActionsLast action
HSAIHesai GroupHold2Aug 20
LIDRAEye, Inc.Buy1May 14
MVISMicroVision, Inc.Hold1May 14

Recent actions

StockRating actionRatingDate
Hesai GroupHSAIReiterateHoldAug 20
Hesai GroupHSAIReiterateHoldMay 20
AEye, Inc.LIDRReiterateBuyMay 14
MicroVision, Inc.MVISReiterateHoldMay 14

References

  1. AmerX Adds Equity Research for Institutional Clients (2026)amerx.com
  2. Equity Research - Dawn of Physical AI - AmerXamerx.com
  3. AmerX research report on WidePoint with rating system disclosures (August 2026)irp.cdn-website.com
  4. NYSE Letter of Acceptance, Waiver and Consent - Americas Executions (2016)nyse.com
  5. Lucid Capital Markets, LLC - FINRA BrokerCheckbrokercheck.finra.org
  6. Floor Brokerage - Lucid Capital Marketslucidcapitalmarkets.com